Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
56,687,119
-
Shares change
-
-496,449
-
Total reported value, excl. options
-
$1,933,242,340
-
Value change
-
-$13,205,166
-
Put/Call ratio
-
73%
-
Number of buys
-
96
-
Number of sells
-
-127
-
Price
-
$34.11
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q1 2024
281 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2024.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,687,119 shares
.
Largest 10 shareholders include BlackRock Inc. (10,362,356 shares), VANGUARD GROUP INC (6,206,814 shares), ARMISTICE CAPITAL, LLC (3,572,000 shares), MACQUARIE GROUP LTD (2,668,996 shares), DIMENSIONAL FUND ADVISORS LP (2,556,921 shares), STATE STREET CORP (2,038,646 shares), Polar Capital Holdings Plc (1,940,510 shares), Stephens Investment Management Group LLC (1,901,776 shares), LOOMIS SAYLES & CO L P (1,597,417 shares), and GW&K Investment Management, LLC (1,339,442 shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.